Description
Retatrutide Peptide – For Laboratory Research Use Only Not for Human Consumption
Product Overview
Retatrutide (also known as LY3437943) is a synthetic long-acting triple agonist peptide that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. It is provided as a high-purity research compound for laboratory investigations into metabolic regulation, energy homeostasis, appetite signaling, and related pathways in cellular and animal models.
Important Legal Notice (UK, EU, USA): This product is sold strictly for research and laboratory use only. It is not for human consumption, not intended for therapeutic, weight management, or any clinical applications in humans or animals, and has not been fully approved by the MHRA, EMA, FDA, or any other regulatory authority for human or veterinary use. All buyers must comply with applicable laws and institutional requirements. Misuse is prohibited.
Key Research Features
- Quantity: Commonly available in 10mg, 15mg, or 20mg vials (contact for custom sizes)
- Form: Lyophilized high-purity powder
- Structure: Fatty acid-modified peptide (~40 amino acids) for extended half-life in experimental settings
- Intended Applications: Studies on multi-receptor agonism, glucose metabolism, lipid regulation, body weight modulation mechanisms, and incretin-glucagon system interactions in controlled laboratory environments.
Retatrutide is a cutting-edge tool for researchers exploring advanced metabolic pharmacology and triple-agonist strategies.
Also known as:
- Retatrutide
- Retatrutide peptide
- Retatrutide research
- LY3437943
- “Retatrutide research peptide for lab use”
- “Buy Retatrutide 10mg / 15mg / 20mg research UK EU USA”
- “Retatrutide triple agonist not for human consumption”
- “Retatrutide GLP-1 GIP glucagon research compound”
- “LY3437943 metabolic pathway studies”
Reta Product Description
Retatrutide (LY3437943) Research Peptide – Triple Receptor Agonist
Advance your metabolic research with Retatrutide, a synthetic triple agonist peptide designed for laboratory studies of GLP-1, GIP, and glucagon receptor pathways. This high-purity compound supports detailed investigations into energy balance, nutrient metabolism, and multi-hormonal signaling in experimental models.
Product Specifications:
- High-purity lyophilized Retatrutide
- Available in multiple vial sizes (10mg, 15mg, 20mg+)
- Fatty acid acylated for research-relevant pharmacokinetics
- For Research Use Only – Not for Human Consumption
Suitable for academic institutions, pharmaceutical R&D, and specialized metabolic research laboratories.
Storage: Store lyophilized at -20°C. Reconstitute using sterile laboratory-grade buffers according to your approved experimental protocols.
Full Disclaimer: Retatrutide is provided exclusively for scientific research purposes. It is not a drug, medication, or supplement. It must not be used on humans or animals. Purchasers are responsible for ensuring full regulatory compliance in their jurisdiction (UK MHRA, EU, US FDA, etc.).
FAQ Section
- What is Retatrutide used for in research? It is studied as a triple agonist in experiments examining metabolic regulation, incretin biology, and glucagon receptor effects.
- Is Retatrutide legal to purchase? Yes, when acquired and used strictly for legitimate laboratory research. It is not approved for human use in the UK, EU, or USA.
- Who can buy Retatrutide? Qualified researchers and institutions. Verification may be required for compliance.
Blog
- “Retatrutide Research: Exploring Triple Agonists in Metabolic Pathway Studies”
- “The Rise of Multi-Receptor Agonists: Retatrutide in Preclinical Research”
- “Incretin and Glucagon Systems: Tools for Advanced Metabolic Investigations”
Reviews
There are no reviews yet.